Aurora Cannabis ROE 2017-2019 | ACB
Current and historical return on equity (ROE) values for Aurora Cannabis (ACB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Aurora Cannabis ROE for the three months ending June 30, 2019 was -0.83%.
|Aurora Cannabis ROE - Return on Equity Historical Data
||TTM Net Income
||Return on Equity
||Medical Products Manufacturing
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.